Ethosuximide (Zarontin®), Serum
Ethosuximide (Zarontin ®), Serum ---- Number 007443 CPT 80168 Synonyms Zarontin ® Special Instructions State other drugs taken by patient. Transfer separated serum or plasma to a plastic transport tube. Depending on the specimen volume and storage time, the decrease in drug level due to absorption may be clinically significant. Storage Instructions...
Ethosuximide for epilepsy - [Medication] - Quest Diagnostics Patient Health Library
Ethosuximide for epilepsy Examples Brand Name Chemical Name Zarontin ethosuximide Ethosuximide requires 2 to 3 oral doses per day. Why It Is Used Ethosuximide is one of the drugs of choice for children who have absence seizures. 1 , 2 Side Effects Ethosuximide may cause severe stomach problems, including: Nausea and vomiting. Topic Contents -...
Prescription Drug Information
(You will be leaving the UMHS site to enter the MEDLINEplus site.) To browse by first letter of generic or brand name drug: A - Am An - Az B C - Ch Ci - Cz D - Dh Di - Dz E F G H I - J K - L M - Mh Mi - Mz N - Nh Ni - Nz O P - Pl Pm - Pz Q - R S - Sn So - Sz T - To Tp - Tz U - V W - Z 0 - 9 - UMHS provides additional drug information on these topics: Anticoagulant - Coumadin/Warfarin...
Specificity Table TOX.xls page 29
author: Biosite Incorporated
LabHorizons Newsletter vol4 no2 2nd qtr 2004.qxd
007740 Acetaminophen (Tylenol ® ), Serum 700005 Acetaminophen, Serum 717330 Amikacin, Serum, Peak/ Trough 007204 Amikacin Peak, Serum 007203 Amikacin Random, Serum 007205 Amikacin Trough, Serum 706705 Amiodarone (Cordarone ® ), Serum 007476 Amitriptyline (Elavil ® ), Serum 017487 Amitriptyline and Nortriptyline 017178 Amobarbital, Serum 007914 Anticonvulsant Profile...
author: ellerb
LabHorizons Newsletter vol4 no2 2nd qtr 2004.qxd page 3
author: ellerb
Esoterix, Inc. -- Test Menu Details
----- Recent Changes Allergy Coagulation Endocrinology Immunology Infectious Disease Molecular Diagnostics Oncology Toxicology Other Test Code Procedure 1323124 Ethosuximide (Zarontin) CPT Code 80168 Specimen Requirement 1 mL serum or plasma, room temperature Pediatric Minimum N/A Methodology Corridor FPIA Toxicology Assay Schedule Assay Time M-F 3 - 5 days Reference Range 40-100 &...
author: Esoterix, Inc.
Esoterix, Inc. -- Test Menu
vivax) 300523 Platelet Antibody, Direct 300521 Platelet Antibody Drug-Induced *** 300520 Platelet Antibody Screen, Indirect (HLA, Platelet Glycoprotein) 500679 Platelet Count 300504 Platelet Factor 4 300805 Platelet Neutralization Procedure 300524 Platelet Specific Antibody (GP IIb/IIIa) 300526 Platelet Specific Antigen PLA1 (HPA-1a) 300531 Platelet Specific Antigen-2 (PLA2)...
author: Esoterix, Inc.
Esoterix, Inc. -- Test Menu
----- Recent Changes Allergy Coagulation Endocrinology Immunology Infectious Disease Molecular Diagnostics Oncology Toxicology Other Test Code Procedure - Zarontin - see 1323124 - Ethosuximide 133691 Zinc (Zn), Serum 133300 Zinc (Zn), Urine 133999 Zinc Protoporphyrins, Whole Blood - Zoloft & Desmethylsertraline - see 1390749 - Sertraline & Desmethylsertraline 1390168...
author: Esoterix, Inc.
http://www.fda.gov/cder/orange/appendix_a.txt
4, ACETAMINOPHEN TYLENOL W/ CODEINE, ACETAMINOPHEN TYLENOL, ACETAMINOPHEN (OTC) TYLOX, ACETAMINOPHEN TYLOX-325, ACETAMINOPHEN TYMTRAN, CERULETIDE DIETHYLAMINE TYZINE, TETRAHYDROZOLINE HYDROCHLORIDE TZ-3, TIOCONAZOLE (OTC) ** U ** U-CORT, HYDROCORTISONE ACETATE U-GENCIN, GENTAMICIN SULFATE UCEPHAN, SODIUM BENZOATE ULO, CHLOPHEDIANOL HYDROCHLORIDE ULTANE, SEVOFLURANE ULTIVA,...
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt
CLINDAMYCIN PHOSPHATE AS MFG IN ZHEJIANG CHINA 14801 24-Mar-00 ZHEJIANG HUAHAI PHARMACEUTICAL CHEM CO LTD LISINOPRIL DIHYDRATE(BULK) AS MFG IN ZHEJIANG PROVINCE PR OF CHINA 14802 22-Mar-00 ARCHIMICA SPA MINOCYCLINE HYDROCHLORIDE AS MFG IN ORIGGIO(VA)ITALY 14804 23-Mar-00 THE 2ND BRANCH FACTORY OF XIANJU PHARMACEUTICAL FACTORY NABUMETONE(BULK)AS MFG IN XIANJU ZHEJIANG PROVINCE PR OF...
FDA Drug Approvals List April 2001
- Drug Approvals for April 2001 Definitions and Notes Original New Drug Applications Original Application #: 020949 Approval Date: 30-APR-01 Trade Name: ACCUNEB Chemical Type: 5 Therapeutic Potential: S Dosage Form: SOLUTION Applicant: DEY LABORATORIES INC Active Ingredient(s): ALBUTEROL SULFATE OTC/RX Status: RX Indication(s): For the treatment of asthma-related bronchospasm in...
Prescription and OTC Drug Product List 10/2002
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -A- AA ABLE 325MG;7.5MG N40464 001 OCT 23, 2002 OCT NEWA -A- AA 325MG;10MG N40464 002 OCT 23, 2002 OCT NEWA -A- AA 650MG;10MG N40476 001 OCT 23, 2002 OCT NEWA -A- AA 750MG;7.5MG N40469 001 OCT 25, 2002 OCT NEWA -A- AA MALLINCKRODT 750MG...
Report.PDF page 10
author: default
0403-4.0.qxd page 4
author: BessingerB
http://www.fda.gov/cder/foi/label/2001/12380s25lbl.PDF page 2
http://www.fda.gov/cder/foi/label/2001/12380s25lbl.PDF page 1
C:\Windows\Desktop\ddrive\My Documents\WPFILES\jwndas\n12380\s02\ 9\N12380 s029 apltr.doc
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville MD 20857 NDA 12- 380/ S- 029 Pfizer Inc Andrews: Please refer to your supplemental new drug application dated October 17, 2001, received October 18, 2001, submitted under section 505( b) of the Federal Food, Drug, and Cosmetic Act for Zarontin (Ethosuximide capsules)
author: Jackie Ware
C:\Windows\Desktop\ddrive\My Documents\WPFILES\jwndas\n12380\s02\ 9\N12380 s029 apltr.doc page 1
author: Jackie Ware
Diagnostics
----- EHRL EHRLICHIOSIS ANTIBODIES - ELAS ELASTASE - FAECAL ------- ELEC ELECTROLYTES ------------ EMIC ELECTRON MICROSCOPY ----- EMP EARLY MORNING PROTEIN --- ENA EXTRACTABLE NUCLEAR AB'S ENDO AUTO AB2-ENDOCRINOPATHY ENTO ENTEROVIRUS (COX/ECHO) -- ENVI ENVIRONMENTAL(AIR)SAMPLES EORD ENTERIC ORG RA AG DET EPIU EPITESTOSTERONE - URINE - ERY ERYTHROPOIETIN ---------- ESR ESR ----------...
Prescription and OTC Drug Product List 1/2001
Prescription and Over-the-Counter Drug Product List - 21st Edition Cumulative Supplement Number 1: January 2001 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE TABLET; ORAL TABLET; ORAL - ADD - ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE BISOPROLOL...
Drug Approvals - Z
Product Name Company Application # Approval Date Letter Posted Label Posted Review Posted ZADITOR (ketotifen fumarate ophthalmic solution) 0.025%, Rx Ciba Vision NDA 21-066 7/2/99 7/6/99 7/6/99 3/31/02 ZADITOR (ketotifen fumarate ophthalmic solution) 0.025%, Rx Ciba Vision NDA 21-066/S4 07/20/01 05/08/03 - ZADITOR Indication: for the prevention of itching of the eye due to allergic...
Reference Listed Drug Labeling Approved in April 2002
Apr 3 ARGATROBAN letter label argatroban injection 20-883 SE1 004 Efficacy claim: For use in patients undergoing percutaneous coronary interventions (PCI) who have or are at risk for heparin-induced thrombocytopenia Apr 5 DIOVAN letter label valsartan tablet 21-283 SE8 002 Efficacy claim: Provides for an alternative starting dose of 160 mg Apr 9 MEGACE letter -- megestrol acetate...
author: USERNAME
Reference Listed Drug Labeling Approved in April 2001
Apr 3 COMPAZINE letter label prochlorperazine maleate tablets prochlorperazine maleate injection prochlorperazine maleate extended-release capsules prochlorperazine maleate suppositories prochlorperazine maleate extended-release capsules 10-571 10-742 11-000 11-127 21-019 S-095 S-065 S-084 S-061 S-001 CRINONE letter label progesterone gel 4% 20-701 S-007 CRINONE letter letter label...
author: USERNAME
http://www.pharmaresearch.com/forms/lam_follow-703.pdf
S., Canada) 910- 256- 0637 (All International Faxes) Registry date of notification _____ _____ _____ Phone day month year Transcribed MATERNAL DATA Patient (Log) ID_______________________ The Registry- assigned ID number ALL LAMOTRIGINE DOSES DURING THIS PREGNANCY INDICATION Epilepsy Bipolar Disorder Other ________________ Course Began (d/ m/ y) Daily Dose (total mg/ day) Course...